Citadel Securities Maintains a 'Neutral' on United Therapeutics (UTHR); Tyvaso Growth Returns, but We Remain Cautious Ahead of FREEDOM-C2 Data

Go back to Citadel Securities Maintains a 'Neutral' on United Therapeutics (UTHR); Tyvaso Growth Returns, but We Remain Cautious Ahead of FREEDOM-C2 Data
United Therapeutics Corp (NASDAQ: UTHR) Delayed: 520.78 -8.36 (1.58%)
Previous Close $529.14    52 Week High $164.04 
Open $524.15    52 Week Low $97.52 
Day High $529.26    P/E 95.21 
Day Low $518.88    EPS $5.47 
Volume 99,632